Androgen-deprivation therapy and risk of dementia in patients with prostate cancer: Clinical outcomes from real-world data

被引:0
|
作者
Elantably, Dina
Wang, Jiasheng
Al Armashi, Abdul Rahman
Al Zubaidi, Anas
Alkrekshi, Akram
机构
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Seidman Canc Ctr, Dept Hematol & Oncol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Case Comprehens Canc Ctr, Seidman Canc Ctr, Cleveland, OH 44106 USA
[4] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[5] Case Western Reserve Univ, MetroHlth Med Ctr, Dept Hematol & Oncol, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5086
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer
    Pao, Jiunn-Bey
    Yang, Ying-Pi
    Huang, Chun-Nung
    Huang, Shu-Pin
    Hour, Tzyh-Chyuan
    Chang, Ta-Yuan
    Lan, Yu-Hsuan
    Lu, Te-Ling
    Lee, Hong-Zin
    Juang, Shin-Hun
    Huang, Chao-Yuan
    Bao, Bo-Ying
    WORLD JOURNAL OF UROLOGY, 2013, 31 (02) : 281 - 287
  • [32] Androgen-Deprivation Bone Loss in Patients With Prostate Cancer
    Abarado, Cynthia
    Mahon, Suzanne M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (02) : 191 - 198
  • [33] Bone mineral density screening in patients with prostate cancer on androgen-deprivation therapy: Data from a single center
    Hariman, Aileen
    Bufalino, Dominick
    Hess, Brian
    Obi, Chike
    Price, Ronald
    Zelisko, Susan
    Emanuele, Nicholas
    Mazhari, Alaleh
    JOURNAL OF CLINICAL UROLOGY, 2014, 7 (05) : 369 - 370
  • [34] Androgen-deprivation therapy impairs left ventricle functions in prostate cancer patients
    Batur Gonenc Kanar
    Beste Ozben
    Murat Sunbul
    Emre Şener
    Onur Ozkan
    Ilker Tınay
    Mustafa Kursat Tigen
    International Urology and Nephrology, 2019, 51 : 1107 - 1112
  • [35] ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEMENTIA IN 55,310 PATIENTS WITH PROSTATE CANCER
    Liu, Jui-Ming
    Wu, Chun-Te
    Hsu, Ren-Jun
    Shen, Chin-Yao
    Lai, Edward Chia-Cheng
    JOURNAL OF UROLOGY, 2020, 203 : E248 - E249
  • [36] Adverse effects of androgen-deprivation therapy in prostate cancer and their management
    Rhee, Handoo
    Gunter, Jennifer H.
    Heathcote, Peter
    Ho, Ken
    Stricker, Phillip
    Corcoran, Niall M.
    Nelson, Colleen C.
    BJU INTERNATIONAL, 2015, 115 : 3 - 13
  • [37] Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan
    Huang, Wen-Kuan
    Liu, Chi-Hung
    Pang, See-Tong
    Liu, Jia-Rou
    Chang, John Wen-Cheng
    Liaw, Chuang-Chi
    Hsu, Cheng-Lung
    Lin, Yung-Chang
    See, Lai-Chu
    JAMA NETWORK OPEN, 2020, 3 (08) : E2015189
  • [38] METABOLIC SYNDROME IN PATIENTS WITH PROSTATE CANCER UNDERGOING INTERMITTENT ANDROGEN-DEPRIVATION THERAPY
    Rezaei, Mohammadali Mohammadzadeh
    Ghoreifi, Alireza
    Rezaei, Mohammadhadi Mohammadzadeh
    Kerigh, Behzad Feyzzadeh
    JOURNAL OF UROLOGY, 2017, 197 (04): : E770 - E770
  • [39] ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEMENTIA IN PATIENTS WITH PROSTATE CANCER OF THE UNITED KINGDOM AND TAIWAN
    Liu, Jui-Ming
    Lau, Wallis C. Y.
    Man, Kenneth K. C.
    Wu, Chun-Te
    Hsu, Ren-Jun
    Shen, Chin-Yao
    Lai, Edward Chia-Cheng
    JOURNAL OF UROLOGY, 2021, 206 : E418 - E418
  • [40] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Egerdie, Blair
    Toriz, Narciso Hernandez
    Feldman, Robert
    Tammela, Teuvo L. J.
    Saad, Fred
    Heracek, Jiri
    Szwedowski, Maciej
    Ke, Chunlei
    Kupic, Amy
    Leder, Benjamin Z.
    Goessl, Carsten
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 745 - 755